ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

NIH Funding Opportunities Listed

March 13, 2009

Weight An Indicator For Risk Of Developing Myeloma

August 31, 2007

Fox Chase-Penn Program Wins Comprehensive Designation; OMB Tries To Limit Number to 21

October 11, 1974

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

October 28, 2011

ORI Progress On Fisher Case Questioned; Panel Not Formed

March 3, 1995

Obama Lifts Ban on Federal Funding for Embryonic Stem Cell Research, Signs Memo on Scientific Integrity

March 13, 2009